ClinicalTrials.Veeva

Menu

Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients

U

University of Sao Paulo General Hospital

Status

Unknown

Conditions

SARS-CoV Infection
Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04714125
FMDCOVID

Details and patient eligibility

About

This study will evaluate the associations between vascular parameters and clinical outcomes in patients hospitalized with COVID-19.

The vascular function and structure of individuals with COVID-19 admitted to the General Hospital of the University of Sao Paulo will be assessed in the first 72 hours of hospitalization. Then, participants will be followed up until hospital discharge/death.

Logistical regressions will be run to evaluate if vascular function/structure can predict ICU admissions, intubation, thrombosis or death.

Full description

This is a prospective cohort study conducted at the General Hospital of the University of São Paulo Medical School (HCFMUSP). Male and female participants with SARS-CoV-2 and recently admitted to the hospital (≤ 72 hours) will be recruited at the emergency department and outpatient clinics at the HCFMUSP. Immediately upon recruitment, participants will perform the assessment of flow mediated dilation of the brachial artery and the assessment of carotid intima-media thickness. Subsequently, they will be followed during the entire period of hospitalization.

The present study will employ as primary endpoint a composite of ICU admission, intubation or mortality during the period of hospitalization. Cardiovascular complications, such as arterial (AE), deep venous (DVP) or pulmonary embolism (PE) , acute myocardial infarction (AMI), stroke, cardiac arrest, atrial fibrillation and acute kidney injury will be considered secondary endpoints.

The association between the vascular parameters and clinical outcomes will be examined by a multivariate logistic regression.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with SARS-CoV-2
  • Recently admitted to the hospital (≤ 72 hours)
  • Not yet proceeded to ICU care

Exclusion criteria

  • Patients transferred from other hospitals
  • Participants in delirium state
  • Participants with a recent history of endotracheal intubation

Trial design

250 participants in 1 patient group

Patients with COVID-19
Description:
Patients hospitalized with COVID-19 from the General Hospital of the University of Sao Paulo, Brazil.

Trial contacts and locations

1

Loading...

Central trial contact

Tiago Peçanha, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems